
The several-month-long educational program Challenger Science 2024 recently concluded with a grand finale. The program focused on supporting the commercialization of research and creating favourable conditions for the successful transfer of technologies and innovations. Among the finalists was doctor Kristína Macáková, who presented the concept of developing new biological markers for the early diagnosis of rheumatoid arthritis. Congratulations!


